MPO and hepatocellular carcinoma: One study reported that HCC (and cholangiocarcinoma) patients had dramatically higher pre-surgery circulating NET levels (measured as MPO-DNA complexes) than healthy controls, and those with high NET levels had significantly shorter recurrence-free and overall survival [89].